CO5540295A2 - Comprimido para tragar que comprende paracetamol - Google Patents
Comprimido para tragar que comprende paracetamolInfo
- Publication number
- CO5540295A2 CO5540295A2 CO03106074A CO03106074A CO5540295A2 CO 5540295 A2 CO5540295 A2 CO 5540295A2 CO 03106074 A CO03106074 A CO 03106074A CO 03106074 A CO03106074 A CO 03106074A CO 5540295 A2 CO5540295 A2 CO 5540295A2
- Authority
- CO
- Colombia
- Prior art keywords
- paracetamol
- antacid
- sodium bicarbonate
- amount
- dose
- Prior art date
Links
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 title abstract 4
- 229960005489 paracetamol Drugs 0.000 title abstract 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract 4
- 229940069428 antacid Drugs 0.000 abstract 4
- 239000003159 antacid agent Substances 0.000 abstract 4
- 230000001458 anti-acid effect Effects 0.000 abstract 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 3
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 3
- 239000007963 capsule composition Substances 0.000 abstract 2
- 239000011736 potassium bicarbonate Substances 0.000 abstract 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 abstract 2
- 235000015497 potassium bicarbonate Nutrition 0.000 abstract 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 abstract 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
- 239000007916 tablet composition Substances 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1.- Una forma de dosis no-efervescente pensada para ser ingerida directamente tal como una composición de tableta o cápsula digerible, que comprende una cantidad terapéuticamente eficaz de paracetamol, un excipiente farmacéuticamente aceptable y una cantidad de antiácido hasta de 55 mg por unidad de dosis, en donde el antiácido es bicarbonato de sodio o bicarbonato de potasio o mezclas de los mismos, con la condición que la forma de dosis no comprende una mezcla de paracetamol y ácido cítrico en una proporción de 85:15 a 90:10 % p/p, bicarbonato de sodio/carbonato de sodio y un portador farmacéuticamente aceptable.2.- Una forma de dosis no-efervescente en forma de una formulación de tableta o cápsula digerible, que comprende una cantidad terapéuticamente eficaz de paracetamol y una cantidad de antiácido hasta de 55 mg, en donde el antiácido es bicarbonato de sodio o bicarbonato de potasio o mezclas de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0114069.8A GB0114069D0 (en) | 2001-06-08 | 2001-06-08 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5540295A2 true CO5540295A2 (es) | 2005-07-29 |
Family
ID=9916252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO03106074A CO5540295A2 (es) | 2001-06-08 | 2003-12-02 | Comprimido para tragar que comprende paracetamol |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7993673B2 (es) |
| EP (1) | EP1392271B1 (es) |
| JP (1) | JP2004533461A (es) |
| KR (1) | KR100846945B1 (es) |
| CN (1) | CN1538837A (es) |
| AR (1) | AR036085A1 (es) |
| AT (1) | ATE389392T1 (es) |
| AU (1) | AU2002317772B2 (es) |
| BR (1) | BR0210224A (es) |
| CA (1) | CA2449520C (es) |
| CO (1) | CO5540295A2 (es) |
| CZ (1) | CZ301449B6 (es) |
| DE (1) | DE60225686T2 (es) |
| DK (1) | DK1392271T3 (es) |
| ES (1) | ES2300452T3 (es) |
| GB (1) | GB0114069D0 (es) |
| HU (1) | HUP0400127A2 (es) |
| MX (1) | MXPA03011317A (es) |
| MY (1) | MY136059A (es) |
| NZ (1) | NZ529974A (es) |
| PL (1) | PL367985A1 (es) |
| TW (1) | TWI326212B (es) |
| WO (1) | WO2002100391A1 (es) |
| ZA (1) | ZA200309172B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2566331C (en) * | 2004-05-28 | 2011-03-15 | Imaginot Pty Ltd. | Oral delivery system |
| JP2008500288A (ja) * | 2004-05-28 | 2008-01-10 | イメイジノット ピーティーワイ エルティーディー | 経口治療用化合物の供給系 |
| US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
| DE102004042139B4 (de) * | 2004-08-31 | 2009-06-10 | Aristocon Verwaltungs- Gmbh | Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit |
| CN100356918C (zh) * | 2004-09-30 | 2007-12-26 | 吴筑华 | 一种治疗肠炎的鞣酸苦参总碱肠溶速释制剂 |
| EP3449928A1 (en) | 2005-11-28 | 2019-03-06 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
| GB0607085D0 (en) * | 2006-04-07 | 2006-05-17 | Smithkline Beecham Corp | Novel compositions |
| DE102007041588A1 (de) * | 2007-09-01 | 2009-03-05 | Lts Lohmann Therapie-Systeme Ag | Arzneimittel mit Hefe |
| GB0813929D0 (en) | 2008-07-30 | 2008-09-03 | Glaxo Group Ltd | Novel method |
| BR112013028668A2 (pt) * | 2011-05-06 | 2017-01-24 | Glaxosmithkline Llc | formulações de paracetamol de liberação sustentada |
| WO2014203140A1 (en) * | 2013-06-22 | 2014-12-24 | Wockhardt Limited | Solid oral pharmaceutical compositions comprising fixed dose combination of acetaminophen, dicyclomine and dextropropoxyphene or salts thereof |
| EP3345591A1 (en) * | 2017-01-06 | 2018-07-11 | Oystershell NV | Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation |
| CN108451916B (zh) * | 2018-06-19 | 2020-08-14 | 重庆国泰康宁制药有限责任公司 | 一种对乙酰氨基酚药物组合物制剂及其制备方法 |
| KR20210094513A (ko) | 2018-11-19 | 2021-07-29 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 알코올-내성 약물 제형 |
| CN117836005A (zh) * | 2021-08-25 | 2024-04-05 | 三菱化学株式会社 | 药物片剂用组合物、使用其的药物片剂及其制造方法 |
| CN115998698B (zh) * | 2023-02-07 | 2024-03-15 | 福州海王福药制药有限公司 | 一种碳酸氢钠片的制备工艺 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3390049A (en) * | 1964-12-23 | 1968-06-25 | Smith Kline French Lab | Pharmaceutical tablets coated with wax-free ammonia solubilized water soluble shellac |
| GB1583602A (en) * | 1977-05-26 | 1981-01-28 | Sterwin Ag | N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives |
| CA1182049A (en) * | 1981-07-13 | 1985-02-05 | Francis J. Sterbenz | Apap antacid composition |
| US4915953A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering acetaminophen or phenylpropanolamine |
| US5073377A (en) * | 1988-11-03 | 1991-12-17 | Miles Inc. | Method of preparing oral dosage forms with a granulating composition |
| CA2021548A1 (en) | 1989-09-01 | 1991-03-02 | Ronald Nash Duvall | Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| US5262179A (en) * | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
| AU646232B2 (en) | 1989-10-02 | 1994-02-17 | Cima Labs, Inc. | Effervescent dosage form and method of administering same |
| CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
| US5750145A (en) * | 1995-07-28 | 1998-05-12 | Bristol-Myers Squibb Company | Stable gelatin coated aspirin tablets |
| US5807580A (en) | 1996-10-30 | 1998-09-15 | Mcneil-Ppc, Inc. | Film coated tablet compositions having enhanced disintegration characteristics |
| US5948787A (en) * | 1997-02-28 | 1999-09-07 | Alza Corporation | Compositions containing opiate analgesics |
| GB9704524D0 (en) * | 1997-03-05 | 1997-04-23 | Smithkline Beecham Plc | Composition |
| US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| WO1999004758A1 (en) * | 1997-07-25 | 1999-02-04 | Elan Corporation Plc | A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| DE19931708A1 (de) * | 1999-07-08 | 2001-01-18 | Bayer Ag | Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen |
| US6277409B1 (en) * | 2000-02-11 | 2001-08-21 | Mcneil-Ppc, Inc. | Protective coating for tablet |
| ES2174734B1 (es) | 2000-11-03 | 2003-10-01 | Belmac S A Lab | Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones. |
-
2001
- 2001-06-08 GB GBGB0114069.8A patent/GB0114069D0/en not_active Ceased
-
2002
- 2002-06-03 PL PL02367985A patent/PL367985A1/xx unknown
- 2002-06-03 CZ CZ20033340A patent/CZ301449B6/cs not_active IP Right Cessation
- 2002-06-03 ES ES02747339T patent/ES2300452T3/es not_active Expired - Lifetime
- 2002-06-03 JP JP2003503213A patent/JP2004533461A/ja active Pending
- 2002-06-03 CA CA2449520A patent/CA2449520C/en not_active Expired - Fee Related
- 2002-06-03 AU AU2002317772A patent/AU2002317772B2/en not_active Ceased
- 2002-06-03 EP EP02747339A patent/EP1392271B1/en not_active Expired - Lifetime
- 2002-06-03 WO PCT/EP2002/006046 patent/WO2002100391A1/en not_active Ceased
- 2002-06-03 DK DK02747339T patent/DK1392271T3/da active
- 2002-06-03 BR BR0210224-2A patent/BR0210224A/pt not_active Application Discontinuation
- 2002-06-03 DE DE60225686T patent/DE60225686T2/de not_active Expired - Lifetime
- 2002-06-03 AT AT02747339T patent/ATE389392T1/de not_active IP Right Cessation
- 2002-06-03 MX MXPA03011317A patent/MXPA03011317A/es active IP Right Grant
- 2002-06-03 KR KR1020037016064A patent/KR100846945B1/ko not_active Expired - Fee Related
- 2002-06-03 NZ NZ529974A patent/NZ529974A/en not_active IP Right Cessation
- 2002-06-03 HU HU0400127A patent/HUP0400127A2/hu unknown
- 2002-06-03 CN CNA028153448A patent/CN1538837A/zh active Pending
- 2002-06-03 US US10/480,960 patent/US7993673B2/en not_active Expired - Fee Related
- 2002-06-06 TW TW091112218A patent/TWI326212B/zh not_active IP Right Cessation
- 2002-06-06 MY MYPI20022100A patent/MY136059A/en unknown
- 2002-06-06 AR ARP020102121A patent/AR036085A1/es unknown
-
2003
- 2003-11-25 ZA ZA200309172A patent/ZA200309172B/en unknown
- 2003-12-02 CO CO03106074A patent/CO5540295A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1392271B1 (en) | 2008-03-19 |
| GB0114069D0 (en) | 2001-08-01 |
| DE60225686T2 (de) | 2009-04-16 |
| US7993673B2 (en) | 2011-08-09 |
| KR100846945B1 (ko) | 2008-07-17 |
| TWI326212B (en) | 2010-06-21 |
| ATE389392T1 (de) | 2008-04-15 |
| BR0210224A (pt) | 2004-04-13 |
| PL367985A1 (en) | 2005-03-21 |
| CZ301449B6 (cs) | 2010-03-03 |
| AR036085A1 (es) | 2004-08-11 |
| DE60225686D1 (de) | 2008-04-30 |
| CA2449520A1 (en) | 2002-12-19 |
| WO2002100391A1 (en) | 2002-12-19 |
| JP2004533461A (ja) | 2004-11-04 |
| ES2300452T3 (es) | 2008-06-16 |
| DK1392271T3 (da) | 2008-06-30 |
| CN1538837A (zh) | 2004-10-20 |
| MXPA03011317A (es) | 2004-03-19 |
| AU2002317772B2 (en) | 2006-04-06 |
| HUP0400127A2 (hu) | 2004-07-28 |
| CA2449520C (en) | 2011-12-06 |
| NZ529974A (en) | 2006-02-24 |
| US20040170681A1 (en) | 2004-09-02 |
| CZ20033340A3 (en) | 2004-05-12 |
| ZA200309172B (en) | 2004-11-25 |
| HK1062896A1 (en) | 2004-12-03 |
| EP1392271A1 (en) | 2004-03-03 |
| KR20040007665A (ko) | 2004-01-24 |
| MY136059A (en) | 2008-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5540295A2 (es) | Comprimido para tragar que comprende paracetamol | |
| AR031682A1 (es) | Composiciones farmaceuticas | |
| ES2191960T3 (es) | Composiciones farmaceuticas que contienen un par acido-base efervescente. | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| UY25611A1 (es) | Formas solidas de dosificacion oral para el tratamiento de diabetes no dependiente de insulina | |
| ES2152966T3 (es) | Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion. | |
| MY118164A (en) | Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia | |
| AR042937A2 (es) | Formulaciones de liberacion sostenida para secretagogos de hormona del crecimiento | |
| AR034132A1 (es) | Analogos de somatostatina, un proceso para su produccion y composicion farmaceutica | |
| AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
| CO5160287A1 (es) | Formulacion de liberacion controlada de divalproex sodico | |
| CO5160272A1 (es) | Combinacion de cerivastatina y fibratos | |
| ES2110212T3 (es) | Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion. | |
| PE68899A1 (es) | Composicion que contiene paracetamol | |
| CO5280073A1 (es) | Composiciones | |
| ES2721899T3 (es) | Composiciones farmacéuticas que comprenden fentanilo para su administración intranasal | |
| UY27277A1 (es) | Método para fabricar una composición farmacéutica de dosis baja que tiene una distribución y potencia del fármaco uniformes | |
| AR054833A1 (es) | Formas de dosificacion de liberacion retardada oral altamemte biodisponibles de succinato de o-desmetilvenlafaxina | |
| AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
| PE3096A1 (es) | Formulacion conteniendo selenio | |
| ATE139438T1 (de) | Kaubare antacida | |
| AU1244199A (en) | Tablets to be crunched or sucked, comprising iron as active principle | |
| MXPA05008403A (es) | Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion. | |
| ES2072647T3 (es) | Composiciones que contienen sales de ranitidina/carboxilato de bismuto. | |
| ES2078838A1 (es) | Procedimiento para preparar una composicion a base de clozapina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted | ||
| FD | Application lapsed |